Status:

COMPLETED

Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma

Lead Sponsor:

Shandong University

Conditions:

Artificial Intelligence

Optical Enhancement Endoscopy

Eligibility:

All Genders

18+ years

Brief Summary

Esophageal squamous cell carcinoma is one of the most common malignant tumor of upper digestive tract. However, the detection rate and diagnosis accuracy of early esophageal squamous cell cancer is lo...

Eligibility Criteria

Inclusion

  • high risk patients for esophageal cancer aged 18 years or older;
  • Histologically verified early esophageal squamous cell cancer.

Exclusion

  • patients whose images of esophagus not suitable for the training, validation and testing the computer-assist diagnosis tool.

Key Trial Info

Start Date :

December 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2020

Estimated Enrollment :

119 Patients enrolled

Trial Details

Trial ID

NCT03759756

Start Date

December 1 2018

End Date

April 1 2020

Last Update

April 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Gastroenterology, Qilu Hospital, Shandong University

Jinan, Shandong, China, 250012

Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma | DecenTrialz